Showing 2,829 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Finance & funding

Biden’s 2023 Budget Invests $9.8B in PrEP and Boosts Other HIV Funding

Editor's pick
POZ
31 March 2022
Injectable & long-acting PrEP

What is the use of anti-HIV injections when those who need it most can't use it?

Editor's pick
Bhekisisa
31 March 2022
Injectable & long-acting PrEP

No breakthrough HIV infections seen in women using injectable PrEP

News
25 March 2022
Sex workers

Sex workers in Uganda say yes to HIV self-testing, no to PrEP

News
22 March 2022
Economic & social inequality

Income May Be the Biggest Determinant of Whether Women Stay on PrEP

Editor's pick
POZ
18 March 2022
Injectable & long-acting PrEP

Community Response to ViiV’s Recent Statements on CAB-LA

Editor's pick
AfroCAB
18 March 2022
Injectable & long-acting PrEP

Unitaid to introduce new long-lasting injection to prevent HIV in Brazil and South Africa, as high-income countries begin deployment

Editor's pick
Unitaid
18 March 2022
Vaginal rings & topical PrEP

Dapivirine vaginal ring: SA rollout put on ice for now

Editor's pick
Health-e
15 March 2022
Vaginal rings & topical PrEP

South Africa Approves Dapivirine Vaginal Ring for Use by Women

Editor's pick
International Partnership for Microbicides
11 March 2022
Mental & emotional health & wellbeing

PrEP increases sexual pleasure, intimacy, and closeness

News
11 March 2022
Bone & joint problems

Better adherence to PrEP is associated with more bone loss

News
9 March 2022
Injectable & long-acting PrEP

MSF response: ViiV will not license new game-changing long-acting HIV prevention drug to generic manufacturers

Editor's pick
Médecins Sans Frontières
4 March 2022
Injectable & long-acting PrEP

ViiV Healthcare statement on voluntary license in enabling access to cabotegravir LA for PrEP in low- and middle-income countries

Editor's pick
ViiV Healthcare
4 March 2022
PrEP programmes & uptake

South African programme provides HIV prevention pills in schools

Editor's pick
Spotlight
2 March 2022
Injectable & long-acting PrEP

Communities demand ViiV/GSK accelerate access to CAB-LA in LMICs

Editor's pick
AfroCAB
1 March 2022
PrEP policies & guidelines

Many Americans still paying high costs months after insurers were ordered to cover HIV preventive care

Editor's pick
CNN
1 March 2022
Transmission & prevention

Top 5 stories on HIV prevention from CROI 2022

News
1 March 2022
PrEP programmes & uptake

Generic PrEP for young, at-risk MSM in the US could be cost-saving and health-enhancing

News
24 February 2022
PrEP science

Long-acting doravirine implants as PrEP to prevent vaginal HIV transmission in mouse study

Editor's pick
i-Base
24 February 2022
Dating, relationships & feelings

Centering Sexual Satisfaction in the PrEP Conversation

Editor's pick
POZ
24 February 2022
Drug interactions & pharmacokinetics

No Interactions Between Hormone Therapy and PrEP in Transgender Women or Men

Editor's pick
NATAP
24 February 2022
Injectable & long-acting PrEP

Start planning HIV prevention injection rollout, South African experts say

Editor's pick
Spotlight
23 February 2022
Injectable & long-acting PrEP

Injected PrEP: breakthrough cases could have been detected sooner

News
22 February 2022
Injectable & long-acting PrEP

Injected PrEP: cabotegravir maintains its advantage over four years

News
17 February 2022